<code id='48904C77FC'></code><style id='48904C77FC'></style>
    • <acronym id='48904C77FC'></acronym>
      <center id='48904C77FC'><center id='48904C77FC'><tfoot id='48904C77FC'></tfoot></center><abbr id='48904C77FC'><dir id='48904C77FC'><tfoot id='48904C77FC'></tfoot><noframes id='48904C77FC'>

    • <optgroup id='48904C77FC'><strike id='48904C77FC'><sup id='48904C77FC'></sup></strike><code id='48904C77FC'></code></optgroup>
        1. <b id='48904C77FC'><label id='48904C77FC'><select id='48904C77FC'><dt id='48904C77FC'><span id='48904C77FC'></span></dt></select></label></b><u id='48904C77FC'></u>
          <i id='48904C77FC'><strike id='48904C77FC'><tt id='48904C77FC'><pre id='48904C77FC'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:1966
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Readout Newsletter: GSK, Viking Therapeutics, mifepristone news
          Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

          SangTan/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewslette

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          How digital tools helped lower hypertension in marginalized patients

          Digitaltoolstobettertrackbloodpressureovertimeandencourageadherencetotreatmentplansareincreasinglyco